Tudor Investment Corp’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 1527 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1500 |
|
|
2024
Q4 | – | Sell |
-3,386
| Closed | -$931K | – | 1508 |
|
|
2024
Q3 | $931K | Sell |
3,386
-57,007
| -94% | -$15.7M | ﹤0.01% | 1032 |
|
|
2024
Q2 | $14.7M | Buy |
+60,393
| New | +$14.7M | 0.08% | 162 |
|
|
2024
Q1 | – | Sell |
-64,096
| Closed | -$12.3M | – | 1428 |
|
|
2023
Q4 | $12.3M | Buy |
64,096
+4,092
| +7% | +$783K | 0.1% | 164 |
|
|
2023
Q3 | $10.6M | Buy |
60,004
+51,377
| +596% | +$9.1M | 0.11% | 153 |
|
|
2023
Q2 | $1.64M | Buy |
+8,627
| New | +$1.64M | 0.02% | 725 |
|
|
2022
Q4 | – | Sell |
-29,859
| Closed | -$5.98M | – | 1521 |
|
|
2022
Q3 | $5.98M | Buy |
29,859
+28,014
| +1,518% | +$5.61M | 0.13% | 173 |
|
|
2022
Q2 | $269K | Buy |
+1,845
| New | +$269K | 0.01% | 1280 |
|
|
2022
Q1 | – | Sell |
-24,057
| Closed | -$4.08M | – | 1505 |
|
|
2021
Q4 | $4.08M | Sell |
24,057
-4,196
| -15% | -$712K | 0.07% | 318 |
|
|
2021
Q3 | $5.33M | Buy |
+28,253
| New | +$5.33M | 0.09% | 206 |
|
|
2021
Q2 | – | Sell |
-19,022
| Closed | -$2.69M | – | 1465 |
|
|
2021
Q1 | $2.69M | Buy |
+19,022
| New | +$2.69M | 0.05% | 384 |
|
|
2020
Q2 | – | Sell |
-3,667
| Closed | -$399K | – | 1143 |
|
|
2020
Q1 | $399K | Sell |
3,667
-2,077
| -36% | -$226K | 0.04% | 578 |
|
|
2019
Q4 | $662K | Buy |
+5,744
| New | +$662K | 0.03% | 632 |
|
|
2019
Q3 | – | Sell |
-29,989
| Closed | -$2.18M | – | 1052 |
|
|
2019
Q2 | $2.18M | Buy |
+29,989
| New | +$2.18M | 0.06% | 294 |
|
|
2015
Q1 | – | Sell |
-3,540
| Closed | -$343K | – | 1418 |
|
|
2014
Q4 | $343K | Buy |
+3,540
| New | +$343K | 0.01% | 948 |
|